Article
Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF.
Journal of immunology (Baltimore, Md. : 1950) - 15 Aug 2006
Jacob Chaim O, Pricop Luminita, Putterman Chaim, Koss Michael N, Liu Yi, Kollaros Maria, Bixler Sarah A, Ambrose Christine M, Scott Martin L, Stohl William
Abstract excerpt
Constitutive overexpression of B cell-activating factor belonging to the TNF family (BAFF) promotes development of systemic lupus erythematosus (SLE), and treatment of SLE mice with BAFF antagonists ameliorates disease. To determine whether SLE can develop de novo in BAFF-deficient hosts, BAFF-deficient New Zealand Mixed (NZM) 2328 (NZM.Baff(-/-)) mice were generated. In NZM.Baff(-/-) mice, spleen B cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
